Thank you, Neda. The first quarter of 2026 was a period of solid execution for Arcturus as we continue to advance our rare disease pipeline and strengthen our leadership team. Because Class I CF is a ...
Arcturus Therapeutics (NASDAQ:ARCT) executives highlighted progress in two rare-disease clinical programs and outlined a ...
Compared with Q4 2025, management shifted from “well on track to initiate dosing” (Q4) to confirming enrollment and dosing are underway (Q1): Payne said in Q1, “Our 12-week Phase II study began ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Thursday reported a loss of $27 million in its first quarter. The San Diego-based company said it had a loss of 95 cents per share.
May's bright stars and classic spring constellations make this the perfect time to learn the sky the old-fashioned way, one ...
North America’s celestial highlights for the weekend ahead, which also apply to mid-northern latitudes in the Northern ...
North America’s celestial highlights for the week ahead, which also apply to mid-northern latitudes in the northern ...
As the glow of Mays full moon fades, darker skies take over, creating ideal conditions to watch one of the seasons most ...
Things will remain a little quiet in our sky this week, but there’s still plenty happening across the world. On Tuesday, ...
Plan your summer 2026 stargazing with our guide to the total solar eclipse, Perseid meteor shower, and planetary conjunctions ...
The Flower Moon will be followed by a rare full Blue Moon on May 31.